All In MedTech

FDA Clearance Tracker · P150040-S020

VisuMax; VISUMAX 800

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 18, 2025

Approved

Time to decision

178 days

Received Jun 23, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150040-S020
Device name
VisuMax; VISUMAX 800
Applicant location
Dublin, CA
Received
Jun 23, 2025
Decided
Dec 18, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P150040

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OTL

FDA's approval statement

As written in FDA's record.

labeling update that includes the Post-Approval study data from the VisuMax SMILE New Enrollment Study for the VisuMax Femtosecond Laser

Source documents

Other decisions for Carl Zeiss Meditec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.